Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient-Reference-Cited by-同舟云学术

Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient

Published:2014-02-06 Issue:4 Volume:36 Page:623-626
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Cho Jang-Hee,Lee Jong-Hak,Park Ga-Young,Lim Jeong-Hoon,Kim Jun-Seop,Kang Yoon-Jung,Kwon Owen,Choi Ji-Young,Park Sun-Hee,Kim Yong-Lim,Kim Hyung-Kee,Huh Seung,Kim Chan-Duck

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0886022X.2014.882238

Reference21 articles.

1. Therapeutic approach to FSGS in children

2. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States

3. Recurrent glomerulonephritis following renal transplantation: an update

4. Recurrent disease in renal transplants

5. Rituximab for refractory focal segmental glomerulosclerosis

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment;Frontiers in Immunology;2023-08-29

2. A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design;Frontiers in Nephrology;2023-05-15

3. Recurrent Renal Disease After Transplantation;Pediatric Solid Organ Transplantation;2023

4. Minimal Change Disease and Focal Segmental Glomerulosclerosis in Adults;Evidence‐Based Nephrology;2022-11-18

5. Management of recurrent focal segmental glomerulosclerosis (FSGS) post renal transplantation;Transplantation Reviews;2022-01